BTG3 and systemic lupus erythematosus: By contrast, data from the Systemic Lupus International Collaborating Clinics Cohort, involving 1137 newly diagnosed SLE patients, showed positive ANA among 92.3% of the patients, and majority of the latter had nuclear (77.1%) or mixed nuclear and cytoplasmic and mitotic cell (15.1%) pattern.